Results 31 to 40 of about 1,807,776 (311)

Transitioning intravenous epoprostenol to oral selexipag in idiopathic pulmonary arterial hypertension: a case report

open access: yesESC Heart Failure, 2023
Intravenous (i.v.) prostacyclin is the cornerstone treatment in high‐risk pulmonary arterial hypertension (PAH) patients. Selexipag is an orally available prostacyclin receptor agonist.
André Alexandre   +7 more
doaj   +1 more source

Role of prostacyclin in pulmonary hypertension [PDF]

open access: yes, 2014
Date of Acceptance: 11/12/2014 This is an open access article distributed under the terms of the Creative Commons Attribution license CC BY-4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is ...
Ali FY   +8 more
core   +3 more sources

COgnitive-Pulmonary Disease [PDF]

open access: yesBioMed Research International, 2014
Over the past few decades, chronic obstructive lung disease (COPD) has been considered a disease of the lungs, often caused by smoking. Nowadays, COPD is regarded as a systemic disease. Both physical effects and effects on brains, including impaired psychological and cognitive functioning, have been demonstrated.
Cleutjens, F.A.H.M.   +4 more
openaire   +3 more sources

Relationship between ID1 and EGFR-TKI Resistance 
in Non-small Cell Lung Cancer

open access: yesChinese Journal of Lung Cancer, 2016
Background and objective Non-small cell lung cancer (NSCLC) presents the highest morbidity and mortality among malignant tumors worldwide. The overall effective rate of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) is 30% to 40 ...
Yuchen BAO   +7 more
doaj   +1 more source

Exosomes and Exosomal miRNA in Respiratory Diseases [PDF]

open access: yes, 2016
Exosomes are nanosized vesicles released from every cell in the body including those in the respiratory tract and lungs. They are found in most body fluids and contain a number of different biomolecules including proteins, lipids, and both mRNA and ...
Adcock, IM   +5 more
core   +4 more sources

Progress in the Metabolomics of Acute Coronary Syndrome

open access: yesReviews in Cardiovascular Medicine, 2023
Acute coronary syndrome (ACS) is a severe type of coronary heart disease (CHD) with increasing prevalence and significant challenges for prevention and treatment.
Fu Zhang   +7 more
doaj   +1 more source

Cavitary Legionella Pneumonia in AIDS: When Intracellular Immunity Failure Leads to Rapid Intrapulmonary Cavitation

open access: yesCase Reports in Pulmonology, 2021
Introduction. Legionella is a frequent cause of bacterial pneumonia in patients with AIDS. While multiple organisms have been associated with cavitary pneumonia in this population, Legionella has not. Clinical Case.
Richard Jesse Durrance   +3 more
doaj   +1 more source

Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management. [PDF]

open access: yes, 2017
Idiopathic pulmonary fibrosis (IPF), a fibrosing interstitial pneumonia of unknown etiology, primarily affects older adults and leads to a progressive decline in lung function and quality of life.
Collard, Harold R, Oldham, Justin M
core   +2 more sources

Comorbidities Associated with Large Abdominal Aortic Aneurysms [PDF]

open access: yes, 2019
BACKGROUND: Abdominal aortic aneurysm has become increasingly important owing to demographic changes. Some other diseases, for example, cholecystolithiasis, chronic obstructive pulmonary disease, and hernias, seem to co-occur with abdominal aortic ...
Althoff, Christian E.   +6 more
core   +1 more source

The patient experience of pulmonary hypertension: a large cross-sectional study of UK patients

open access: yesBMC Pulmonary Medicine, 2019
Background Pulmonary Hypertension Association UK (PHA-UK) is the only charity in the UK especially for people affected by pulmonary hypertension (PH).
Iain Armstrong   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy